FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

391716003: Acrivastine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2692339012 Acrivastine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2755879010 Acrivastine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
789131000172113 acrivastine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Acrivastine Is a Non-sedating antihistamine false Inferred relationship Some
Acrivastine Is a Pyridine and/or pyridine derivative true Inferred relationship Some
Acrivastine This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Histamine H1 receptor antagonist (disposition) true Inferred relationship Some
Acrivastine Is a Histamine H1 receptor antagonist true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Acrivastine adverse reaction Causative agent (attribute) True Acrivastine Inferred relationship Some 1
Allergy to acrivastine Causative agent (attribute) False Acrivastine Inferred relationship Some
Product containing acrivastine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Acrivastine Inferred relationship Some 1
Product containing precisely acrivastine 8 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Acrivastine Inferred relationship Some
Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Acrivastine Inferred relationship Some
Acrivastine+pseudoephedrine hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Acrivastine Inferred relationship Some
Product containing acrivastine and pseudoephedrine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Acrivastine Inferred relationship Some 2
Allergy to acrivastine Causative agent (attribute) True Acrivastine Inferred relationship Some 1
Product containing precisely acrivastine 8 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Acrivastine Inferred relationship Some 1
Product containing precisely acrivastine 8 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Acrivastine Inferred relationship Some 1
Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Acrivastine Inferred relationship Some 2
Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Acrivastine Inferred relationship Some 2
Acrivastine- and pseudoephedrine-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Acrivastine Inferred relationship Some 2
Acrivastine-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Acrivastine Inferred relationship Some 1
Product containing precisely acrivastine 8 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Acrivastine Inferred relationship Some 1
Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Acrivastine Inferred relationship Some 2
Acrivastine only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Acrivastine Inferred relationship Some 1
Product containing only acrivastine and pseudoephedrine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Acrivastine Inferred relationship Some 2
Acrivastine and pseudoephedrine only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Acrivastine Inferred relationship Some 2
Acrivastine only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Acrivastine Inferred relationship Some 1

Reference Sets

Description inactivation indicator reference set

Back to Start